Sucampo Appoints Andrew Smith, FCMA, CGMA as CFO
30 janv. 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the appointment of Andrew Smith, FCMA, CGMA...
AMITIZA(R) (lubiprostone) Mutual Recognition Procedure Closes With Recommendation for Approval in European Countries
30 janv. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the successful completion of the European...
Robert J. Spiegel, M.D., FACP Joins Sucampo's Board of Directors
21 janv. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Robert J. Spiegel, M.D., FACP has...
Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada
30 déc. 2014 17h00 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Dec. 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Health Canada has accepted the...
Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's
12 nov. 2014 17h31 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd., Takeda Pharmaceutical...
Sucampo Announces Third Quarter 2014 Financial Results
06 nov. 2014 06h45 HE
|
Sucampo Pharmaceuticals Inc
Strong Revenue and Sales Growth for AMITIZA
Raises 2014 Earnings Guidance, Excluding Special Items
CEO Peter Greenleaf to Provide Update on Significant Progress Against Strategic Plan...
Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs
23 oct. 2014 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced three executive appointments that expand and...
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
21 oct. 2014 18h00 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda...
Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda
14 oct. 2014 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it signed on October 9, 2014 an...
Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update
05 août 2014 06h15 HE
|
Sucampo Pharmaceuticals Inc
Positive Net Income Driven by Strong Revenue Growth in Product Royalty and Product Sales
CEO Peter Greenleaf to Discuss Results of Sucampo's Strategic Review
Company Raises Full Year 2014...